Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks -- Ignore unavailable to you. Want to Upgrade?

To: - with a K who wrote (124)	10/28/2005 2:10:37 PM
From: RockyBalboa	Respond to of 428

... A billion is a lot of money, and I’m betting some of it WILL be spent for rapid flu tests for the five uses Caren identified, above. CBMX Combimatrix might be a good candidate, NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Oct. 26, 2005--Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that its CombiMatrix Group has launched a new comprehensive influenza DNA microarray as well as services for the typing of influenza strains. CombiMatrix's Influenza Microarray is now a member of the CatalogArray(TM) product line and can detect and accurately type flu strains using a protocol that requires less than four hours start to finish.